Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 12796

1.

Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India.

Madabhavi I, Modi G, Panchal H, Patel A, Revannasiddaiah S, Anand A, Parikh S, Joshi K, Sarkar M.

Int J Hematol Oncol Stem Cell Res. 2017 Oct 1;11(4):296-300.

2.

Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study.

Volpato S, Montagnese S, Zanetto A, Turco M, De Rui M, Ferrarese A, Amodio P, Germani G, Senzolo M, Gambato M, Russo FP, Burra P.

BMJ Open Gastroenterol. 2017 Dec 21;4(1):e000183. doi: 10.1136/bmjgast-2017-000183. eCollection 2017.

3.

Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management.

Papadopoulos N, Argiana V, Deutsch M.

Ann Gastroenterol. 2018 Jan-Feb;31(1):35-41. doi: 10.20524/aog.2017.0204. Epub 2017 Oct 26. Review.

4.

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance.

Frias M, Rivero-Juárez A, Rodriguez-Cano D, Camacho Á, López-López P, Risalde MÁ, Manzanares-Martín B, Brieva T, Machuca I, Rivero A.

Sci Rep. 2018 Jan 12;8(1):659. doi: 10.1038/s41598-017-17531-7.

5.

Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs.

Jordan AE, Perlman DC, Reed J, Smith DJ, Hagan H.

Front Public Health. 2017 Dec 18;5:348. doi: 10.3389/fpubh.2017.00348. eCollection 2017.

6.

Lichen planus following tetanus-diphtheria-acellular pertussis vaccination: A case report and review of the literature.

Rosengard HC, Wheat CM, Tilson MP, Cuda JD.

SAGE Open Med Case Rep. 2018 Jan 4;6:2050313X17750335. doi: 10.1177/2050313X17750335. eCollection 2018.

7.

Single-Domain Antibodies As Therapeutics against Human Viral Diseases.

Wu Y, Jiang S, Ying T.

Front Immunol. 2017 Dec 13;8:1802. doi: 10.3389/fimmu.2017.01802. eCollection 2017. Review.

8.

Genome Wide Mapping of Peptidases in Rhodnius prolixus: Identification of Protease Gene Duplications, Horizontally Transferred Proteases and Analysis of Peptidase A1 Structures, with Considerations on Their Role in the Evolution of Hematophagy in Triatominae.

Henriques BS, Gomes B, da Costa SG, Moraes CDS, Mesquita RD, Dillon VM, Garcia ES, Azambuja P, Dillon RJ, Genta FA.

Front Physiol. 2017 Dec 12;8:1051. doi: 10.3389/fphys.2017.01051. eCollection 2017.

9.

Engineered Livers for Infectious Diseases.

Gural N, Mancio-Silva L, He J, Bhatia SN.

Cell Mol Gastroenterol Hepatol. 2017 Nov 22;5(2):131-144. doi: 10.1016/j.jcmgh.2017.11.005. eCollection 2018. Review.

10.

Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study.

Zou X, Xu Y, Chen W, Xia Y, Liu Y, Gong C, Ling L.

Subst Abuse Treat Prev Policy. 2018 Jan 10;13(1):1. doi: 10.1186/s13011-017-0140-3.

11.

The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.

Mahmud S, Akbarzadeh V, Abu-Raddad LJ.

Sci Rep. 2018 Jan 9;8(1):150. doi: 10.1038/s41598-017-18296-9.

12.

Theory Meets Experiment: Metal Ion Effects in HCV Genomic RNA Kissing Complex Formation.

Sun LZ, Heng X, Chen SJ.

Front Mol Biosci. 2017 Dec 22;4:92. doi: 10.3389/fmolb.2017.00092. eCollection 2017. Review.

13.

Global elimination of hepatitis C virus infection: Progresses and the remaining challenges.

Taherkhani R, Farshadpour F.

World J Hepatol. 2017 Nov 28;9(33):1239-1252. doi: 10.4254/wjh.v9.i33.1239. Review.

14.

Genetic variations in NF-κB were associated with the susceptibility to hepatitis C virus infection among Chinese high-risk population.

Tian T, Wang J, Huang P, Li J, Yu R, Fan H, Xia X, Han Y, Zhang Y, Yue M.

Sci Rep. 2018 Jan 8;8(1):104. doi: 10.1038/s41598-017-18463-y.

15.

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.

Takata R, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2017 Dec;96(48):e8761. doi: 10.1097/MD.0000000000008761.

16.

Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.

Collins LF, Chan A, Zheng J, Chow SC, Wilder JM, Muir AJ, Naggie S.

Open Forum Infect Dis. 2017 Dec 9;5(1):ofx264. doi: 10.1093/ofid/ofx264. eCollection 2018 Jan.

17.
18.

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers.

Costa MB, Picon PD, Sander GB, Cuni HN, Silva CV, Meireles RP, Góes ACMA, Batoreu NM, Maia MLS, Albuquerque EM, Matos DCS, Saura PL.

BMC Pharmacol Toxicol. 2018 Jan 4;19(1):1. doi: 10.1186/s40360-017-0192-z.

19.

Human Immunodeficiency Virus (HIV) and Hepatitis Virus Coinfection among HIV-Infected Korean Patients: The Korea HIV/AIDS Cohort Study.

Kim YC, Ahn JY, Kim JM, Kim YJ, Park DW, Yoon YK, Song JY, Kim SW, Lee JS, Choi BY, Choi YS, Choi JY, Han MG, Kang C, Choi JY.

Infect Chemother. 2017 Dec;49(4):268-274. doi: 10.3947/ic.2017.49.4.268.

20.

Efficacy and safety of sofosbuvir-based therapies in patients with advanced liver disease in a real-life cohort.

Kutala BK, Mouri F, Castelnau C, Bouton V, Giuily N, Boyer N, Asselah T, Marcellin P.

Hepat Med. 2017 Dec 18;9:67-73. doi: 10.2147/HMER.S149578. eCollection 2017.

Supplemental Content

Loading ...
Support Center